Belite Bio Stock (NASDAQ: BLTE)
|Day Range32.59 - 34||52 Wk Range8.8 - 44.7||Open / Close33.01 / 33.55||Float / Outstanding- / 24.9M|
|Vol / Avg.18.5K / 64.8K||Mkt Cap841.5M||P/E-||50d Avg. Price32.94|
|Div / Yield-||Payout Ratio-||Total Float-||EPS-|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Belite Bio (NASDAQ: BLTE) through any online brokerage.
The latest price target for Belite Bio (NASDAQ: BLTE) was reported by HC Wainwright & Co. on Monday, August 1, 2022. The analyst firm set a price target for 58.00 expecting BLTE to rise to within 12 months (a possible 71.39% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Belite Bio (NASDAQ: BLTE) is $33.84 last updated September 30, 2022, 8:00 PM UTC.
There are no upcoming dividends for Belite Bio.
Belite Bio’s H1 earnings are confirmed for Wednesday, August 10, 2022.
There is no upcoming split for Belite Bio.
Belite Bio is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.